One woman's low is another woman's high: Paradoxical effects of the menstrual cycle

Psychoneuroendocrinology

Volumn 36, Issue 1, 2011, Pages 68-76

  Kiesner, Jeff ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anxiety; Depression; Menstrual; Paradoxical; Premenstrual; Steroid

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; UNIVERSITY STUDENT;

ADULT; AFFECT; DEPRESSIVE DISORDER; EMOTIONS; FEMALE; HUMANS; INCIDENCE; MENSTRUAL CYCLE; ONLINE SYSTEMS; PREMENSTRUAL SYNDROME; QUESTIONNAIRES; REGRESSION ANALYSIS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 78649869702     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.06.007     Document Type: Article

References (39)

1. Abraham S. Premenstrual or postmenstrual syndrome. Med. J. Aust. 1984, 141:327-328.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. fourth ed.
3. A modulators. Psychoneuroendocrinology 2009, 34:1121-1132.
4. Bancroft J., Boyle H., Warner P., Fraser H.M. The use of an LHRH agonist, Buserelin, in the long-term management premenstrual syndrome. Clin. Endocrinol. 1987, 27:171-182.
5. Björn I., Sundström-Poromaa I., Bixo M., Nyberg S., Bäckström G., Bäckström T. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J. Clin. Endocrinol. Metab. 2003, 88:2026-2030.
6. Bloch M., Rotenberg N., Koren D., Klein E. Risk factors associated with the development of postpartum mood disorders. J. Affect. Disord. 2005, 88:9-18.
7. Bloch M., Rotenberg N., Koren D., Klein E. Risk factors for early postpartum depressive symptoms. Gen. Hosp. Psychiatry 2006, 28:3-8.
8. Bryk A.S., Raudenbush S.W. Hierarchical Linear Models: Application and Data Analysis Methods 1992, Sage Publications, Newbury Park.
9. Freeman E.W. Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause. Dialogues Clin. Neurosci. 2002, 4:177-191.
10. Freeman E.W., Rickels K., Schweizer E., Ting T. Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms. Psychol. Med. 1995, 25:309-315.
11. Freeman E.W., Sammel M.D., Lin H., Nelson D.B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry 2006, 63:375-382.
12. Freeman E.W., Sammel M.D., Rinaudo P.J., Sheng L. Premenstrual syndrome as a predictor of menopausal symptoms. Obstet. Gynecol. 2004, 103:960-966.
13. Freeman E.W., Sondheimer S., Weinbaum P.J., Rickels K. Evaluating premenstrual symptoms in medical practice. Obstet. Gynecol. 1985, 65:500-505.
14. Gallant S.J., Popiel D.A., Hoffman D.M., Chakraborty P.K., Hamilton J.A. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder: Part II. What makes the "Real" difference?. Psychosom. Med. 1992, 54:167-181.
15. Gregoire A.J., Kumar R., Everitt B., Henderson A.F., Studd J.W. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996, 347:930-933.
16. Halbreich U., Borenstein J., Pearlstein T., Kahn L.S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003, 28:1-23.
17. Halbreich U., O'Brien S., Eriksson E., Bäckström T., Yonkers K.A., Freeman E.W. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?. CNS Drugs 2006, 20:523-547.
18. Harlow B.L., Cohen L.S., Otto M.W., Spiegelman D., Cramer D.W. Prevalence and predictors of depressive symptoms in older premenopausal women. Arch. Gen. Psychiatry 1999, 56:418-424.
19. Huo L., Straub R.E., Roca C., Schmidt P.J., Shi K., Vakkalanka R., Weinberger D.R., Rubinow D.R. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol. Psychiatry 2007, 62:925-933.
20. Kiesner J. Physical characteristics of the menstrual cycle and premenstrual depressive symptoms. Psychol. Sci. 2009, 20:763-770.
21. Kiesner J., Pastore M. Day-to-day co-variations of psychological and physical symptoms of the menstrual cycle: insights to individual differences in steroid reactivity. Psychoneuroendocrinology. 2010, 35:350-363.
22. May R.R. Mood shifts and the menstrual cycle. J. Psychosom. Res. 1976, 20:125-130.
23. Metcalf M.G., Livesey J.H. Distribution of positive moods in women with the premenstrual syndrome and in normal women. J. Psychosom. Res. 1995, 39:609-618.
24. Parlee M.B. Changes in moods and activation levels during the menstrual cycle in experimentally naive subjects. Psychol. Women Quart. 1982, 7:119-131.
25. Pincus S.M., Schmidt P.J., Palladino-Negro P., Rubinow D.R. Differentiation of women with premenstrual dysphoric disorder, recurrent brief depression, and healthy controls by daily mood rating dynamics. J. Psychiatr. Res. 2008, 42:337-347.
26. Rapkin A. A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder. Psychoneuroendocrinology 2003, 28:39-53.
27. Reid R.L. Endogenous opioid activity and the premenstrual syndrome. Lancet 1983, 322:786.
28. Reid R.L. Premenstrual Syndrome. Curr. Probl. Obstet. Gynecol. Fertil. 1985, 8:1-57.
29. Reid R.L. Premenstrual syndrome. Am. Assoc. Clin. Chem. Endocrinol. 1987, 5:1-12.
30. Richards M., Rubinow D.R., Daly R.C., Schmidt P.J. Premenstrual symptoms and perimenopausal depression. Am. J. Psychiatry 2006, 163:133-137.
31. Ross C., Coleman G., Stojanovska C. Prospectively reported symptom change across the menstrual cycle in users and non-users of oral contraceptives. J. Psychosom. Obstet. Gynecol. 2003, 24:15-29.
32. Schmidt P.J., Nieman L.K., Danaceau M.A., Adams L.F., Rubinow D.R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 1998, 338:209-216.
33. Soares C.N., Cohen L.S., Otto M.W., Harlow B.L. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard study of moods and cycles. J. Womens Health Gend. Based Med. 2001, 10:873-878.
34. Sternfeld B., Swindle R., Chawla A., Long S., Kennedy S. Severity of premenstrual symptoms in a health maintenance organization population. Obstet. Gynecol. 2002, 99:1014-1024.
35. Strine T.W., Chapman D.P., Ahluwalia I.B. Menstrual-related problems and psychological distress among women in the United States. J. Womens Health 2005, 14:316-323.
36. Sveinsdóttir H., Bäckström T. Menstrual cycle symptom variation in a community sample of women using and not using oral contraceptives. Acta Obstet. Gynecol. Scand. 2000, 79:757-764.
37. Takeda T., Tasaka K., Sakata M., Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch. Womens Mental Health 2006, 9:209-212.
38. Wittchen H.U., Becker E., Lieb R., Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol. Med. 2002, 32:119-132.
39. Woods N.F., Most A., Dery G.K. Prevalence of perimenstrual symptoms. Am. J. Public Health 1982, 72:1257-1264.